GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (NYSE:TMO) » Definitions » Piotroski F-Score

TMO (Thermo Fisher Scientific) Piotroski F-Score : 6 (As of Dec. 15, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Thermo Fisher Scientific Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Thermo Fisher Scientific has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Thermo Fisher Scientific's Piotroski F-Score or its related term are showing as below:

TMO' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 7   Max: 9
Current: 6

During the past 13 years, the highest Piotroski F-Score of Thermo Fisher Scientific was 9. The lowest was 4. And the median was 7.


Thermo Fisher Scientific Piotroski F-Score Historical Data

The historical data trend for Thermo Fisher Scientific's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thermo Fisher Scientific Piotroski F-Score Chart

Thermo Fisher Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 8.00 7.00 5.00 5.00

Thermo Fisher Scientific Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 5.00 6.00 8.00 6.00

Competitive Comparison of Thermo Fisher Scientific's Piotroski F-Score

For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thermo Fisher Scientific's Piotroski F-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Thermo Fisher Scientific's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was 1630 + 1328 + 1548 + 1630 = $6,136 Mil.
Cash Flow from Operations was 3723 + 1251 + 1960 + 2166 = $9,100 Mil.
Revenue was 10886 + 10345 + 10541 + 10598 = $42,370 Mil.
Gross Profit was 4393 + 4205 + 4347 + 4328 = $17,273 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(97057 + 98726 + 97095 + 98496 + 100364) / 5 = $98347.6 Mil.
Total Assets at the begining of this year (Sep23) was $97,057 Mil.
Long-Term Debt & Capital Lease Obligation was $31,197 Mil.
Total Current Assets was $23,783 Mil.
Total Current Liabilities was $14,601 Mil.
Net Income was 1576 + 1289 + 1361 + 1715 = $5,941 Mil.

Revenue was 11450 + 10710 + 10687 + 10574 = $43,421 Mil.
Gross Profit was 4606 + 4140 + 4251 + 4316 = $17,313 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(90536 + 97154 + 94658 + 94105 + 97057) / 5 = $94702 Mil.
Total Assets at the begining of last year (Sep22) was $90,536 Mil.
Long-Term Debt & Capital Lease Obligation was $30,489 Mil.
Total Current Assets was $23,092 Mil.
Total Current Liabilities was $14,158 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Thermo Fisher Scientific's current Net Income (TTM) was 6,136. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Thermo Fisher Scientific's current Cash Flow from Operations (TTM) was 9,100. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=6136/97057
=0.06322058

ROA (Last Year)=Net Income/Total Assets (Sep22)
=5941/90536
=0.06562031

Thermo Fisher Scientific's return on assets of this year was 0.06322058. Thermo Fisher Scientific's return on assets of last year was 0.06562031. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Thermo Fisher Scientific's current Net Income (TTM) was 6,136. Thermo Fisher Scientific's current Cash Flow from Operations (TTM) was 9,100. ==> 9,100 > 6,136 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=31197/98347.6
=0.3172116

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=30489/94702
=0.32194674

Thermo Fisher Scientific's gearing of this year was 0.3172116. Thermo Fisher Scientific's gearing of last year was 0.32194674. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=23783/14601
=1.62886104

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=23092/14158
=1.63102133

Thermo Fisher Scientific's current ratio of this year was 1.62886104. Thermo Fisher Scientific's current ratio of last year was 1.63102133. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Thermo Fisher Scientific's number of shares in issue this year was 384. Thermo Fisher Scientific's number of shares in issue last year was 388. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=17273/42370
=0.40767052

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=17313/43421
=0.39872412

Thermo Fisher Scientific's gross margin of this year was 0.40767052. Thermo Fisher Scientific's gross margin of last year was 0.39872412. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=42370/97057
=0.4365476

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=43421/90536
=0.47959928

Thermo Fisher Scientific's asset turnover of this year was 0.4365476. Thermo Fisher Scientific's asset turnover of last year was 0.47959928. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+1+1+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Thermo Fisher Scientific has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Thermo Fisher Scientific  (NYSE:TMO) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Thermo Fisher Scientific Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Thermo Fisher Scientific Business Description

Address
168 Third Avenue, Waltham, MA, USA, 02451
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).
Executives
Marc N Casper officer: Senior Vice President C/O THERMO FISHER SCIENTIFIC, 168 THIRD AVENUE, WALTHAM MA 02451
Gianluca Pettiti officer: Executive Vice President C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael A Boxer officer: Sr. VP and Gen. Counsel 168 THIRD AVENUE, WALTHAM MA 02451
Lisa P. Britt officer: Sr. VP and Chief HR Officer 168 THIRD AVENUE, WALTHAM MA 02451
Joseph R. Holmes officer: VP & Chief Accounting Officer 168 THIRD AVENUE, WALTHAM MA 02451
Michel Lagarde officer: Senior Vice President 450 LEXINGTON AVE., 31ST FLOOR, NEW YORK NY 10017
Stephen Williamson officer: Sr. VP and CFO 81 WYMAN STREET, WALTHAM MA 02451
Debora L Spar director C/O GOLDMAN, SACHS & CO., 200 WEST STREET, NEW YORK NY 10282
Jennifer M Johnson director C/O FRANKLIN RESOURCES, INC., ONE FRANKLIN PARKWAY, SAN MATEO CA 94403-1906
Jim P Manzi director 81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Ruby R Chandy director 630 DUNDEE ROAD, SUITE 400, NORTHBROOK IL 60062
Mark P Stevenson officer: Executive Vice President 850 LINCOLN CENTRE DRIVE, FOSTER CITY CA 94404
R. Alexandra Keith director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
Peter E Hornstra officer: Chief Accounting Officer 81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Syed A. Jafry officer: Sr. Vice President 345 E. MAIN STREET, WARSAW IN 46580